Research for Clinicians
Diagnostic criteria for FTD reviewed
Fourteen years later: Reviewing the diagnostic criteria for behavioral-variant frontotemporal dementia
Abstract
INTRODUCTION: Diagnosis of behavioral-variant frontotemporal dementia (bvFTD) requires the presence of at least three of six core features. The contribution of each criterion toward diagnosis, however, remains unclear. We aimed to determine the frequency and combinations of diagnostic criteria at presentation and their contribution to survival.
Podcast!
Fronto-Temporal Dementia
differential diagnosis in clinical practice
Dr Amy Brodtman is a leading neurologist
known for her outstanding work in younger onset and frontotemporal dementia,
combining clinical care with impactful research.
Dr Trey Bateman talks with Dr Amy Brodtman about the complexities of diagnosing FTD and related disorders.
New genetic therapy could be a gamechanger for MND and frontotemporal dementia
From Macquarie University | The Lighthouse
“Macquarie University neuroscientists have developed a single-dose genetic medicine that has been proven to halt the progression of both motor neurone disease (MND) and frontotemporal dementia (FTD) in mice – and may even offer the potential to reverse some of the effects of the fatal diseases.
It may also hold opportunities for treating more common forms of dementia, such as Alzheimer’s disease, which is the second most common cause of death in Australia after heart disease.“
